Skip to content

Ayurvedic Management of Primary Hypothyroidism Using Haritakyadi Vati

AN OPEN RANDOMISED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFECT OF HARITAKYADI VATI IN THE MANAGEMENT OF PRIMARY HYPOTHYROIDISM - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110550
Enrollment
290
Registered
2026-05-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E018- Other iodine-deficiency related thyroid disorders and allied conditions

Interventions

None listed

Sponsors

Dr. Shivanikumari Rajesh Dubey
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Both sexes 2. Age between 20 to 60 years. 3. Signs and symptoms of Primary Hypothyroidism. 4. Newly diagnosed or untreated patients of Primary Hypothyroidism. 5. Subjects who are willing to give written informed consent. 6. Serum T3 and T4 within normal range and Serum TSH level above 5.5 MicroUnit per ml, but below 10 MicroUnit per ml.

Exclusion criteria

Exclusion criteria: 1) Pregnant & lactating mothers. 2) Hypothyroidism due to excessive radiation therapy in treating cancer like lymphoma. 3) Malignancy of Thyroid Gland 4) Any other metabolic or systemic disease condition where other treatment is urgent and can disturb the regimen. (HIV, Diabetes Mellitus, Cardiovascular disease, Tuberculosis etc) 5) Patient having myxoedema coma. 6) Patients having X-Syndrome, Down s Syndrome, Turner s Syndrome, Klinefelter s Syndrome, carpel tunnel Syndrome will be excluded. 7) Patient having Hypothyroidism due to Hypothalamic and Pituitary dysfunction. 8) Present history of any mental disorder. 9) Patient with Chronic Hyperacidity.

Design outcomes

Primary

MeasureTime frame
RELIEF IN SUBJECTIVE PARAMETERS 1) Fatigue (Daurbalya) 2) Poor appetite (Agnimandya) 3) Dyspnoea (Shramshwas) 4) Hairfall (khalitya) Timepoint: Assessment will be done on 0 day (Before Treatment) and on 30th day , 60th Day and 90th Day (After the initiation of Trial )

Secondary

MeasureTime frame
RELIEF IN OBJECTIVE PARAMETERES 1) Serum TSH level. 2) Weight in kg.Timepoint: Assessment will be done on 0 day (Before Treatment) and on 30th day , 60th Day and 90th Day (After the initiation of Trial )

Countries

India

Contacts

Public ContactDr Shivanikumari Rajesh Dubey

R. A. Podar ayurvedic medical college and hospital Worli, Mumbai

drmrevadkar@yahoo.com9820625630

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026